An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC (PSMAddition)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04720157 |
|
Recruitment Status :
Active, not recruiting
First Posted : January 22, 2021
Last Update Posted : April 24, 2024
|
Sponsor:
Novartis Pharmaceuticals
Collaborators:
Alliance Foundation Trials, LLC.
RTOG Foundation, Inc.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | July 23, 2025 |
| Estimated Study Completion Date : | February 11, 2026 |